CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 78.1% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
77.90
4.06%
Market Trading Hours* (UTC) Opens on Monday at 08:00

Mon - Fri: 08:00 - 16:20

  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading сonditions
Spread 0.60
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.015664 %
Charges from full value of position ($-2.98)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.015664%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.006558 %
Charges from full value of position ($-1.25)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.006558%
Overnight fee time 22:00 (UTC)
Min traded quantity 1
Currency CHF
Margin 5%
Stock exchange Switzerland
Commission on trade 0%

*Information provided by Capital.com

DocMorris AG ESG Risk Ratings

High Medium Low Negligible

‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.

More ESG coverage

Key Stats
Prev. Close* 81.2
Open* 81.75
1-Year Change* 65.65%
Day's Range* 74.95 - 81.75
52 wk Range 28.52-81.35
Average Volume (10 days) 107.04K
Average Volume (3 months) 2.11M
Market Cap 998.78M
P/E Ratio -100.00K
Shares Outstanding 11.76M
Revenue 1.25B
EPS -12.60
Dividend (Yield %) N/A
Beta 1.45
Next Earnings Date Mar 21, 2024

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Mar 1, 2024 77.90 -3.65 -4.48% 81.55 82.35 74.95
Feb 29, 2024 81.20 0.05 0.06% 81.15 83.20 77.90
Feb 28, 2024 82.80 -0.40 -0.48% 83.20 83.50 79.90
Feb 27, 2024 84.00 -0.35 -0.41% 84.35 85.35 82.60
Feb 26, 2024 84.95 -1.85 -2.13% 86.80 87.60 83.35
Feb 23, 2024 86.80 0.50 0.58% 86.30 87.65 84.95
Feb 22, 2024 86.35 -1.50 -1.71% 87.85 89.15 84.40
Feb 21, 2024 85.50 -3.45 -3.88% 88.95 90.25 85.50
Feb 20, 2024 88.30 -2.50 -2.75% 90.80 90.90 87.65
Feb 19, 2024 91.50 0.10 0.11% 91.40 91.95 89.10
Feb 16, 2024 92.10 -0.80 -0.86% 92.90 93.50 89.90
Feb 15, 2024 91.40 -3.60 -3.79% 95.00 95.80 91.40
Feb 14, 2024 93.50 2.45 2.69% 91.05 94.10 87.15
Feb 13, 2024 91.35 -5.60 -5.78% 96.95 97.10 89.75
Feb 12, 2024 95.90 -3.05 -3.08% 98.95 101.25 95.60
Feb 9, 2024 96.85 5.05 5.50% 91.80 97.50 91.80
Feb 8, 2024 89.20 1.15 1.31% 88.05 91.80 87.50
Feb 7, 2024 87.35 0.55 0.63% 86.80 88.50 85.45
Feb 6, 2024 86.40 2.25 2.67% 84.15 86.85 82.95
Feb 5, 2024 83.35 3.15 3.93% 80.20 83.95 79.50

DOCMORRIS AG ORD Events

Time (UTC) Country Event
Thursday, March 21, 2024

Time (UTC)

10:00

Country

CH

Event

Full Year 2023 DocMorris AG Earnings Call
Full Year 2023 DocMorris AG Earnings Call

Forecast

-

Previous

-

Time (UTC)

10:59

Country

CH

Event

Full Year 2023 Zur Rose Group AG Earnings Release
Full Year 2023 Zur Rose Group AG Earnings Release

Forecast

-

Previous

-
Tuesday, April 16, 2024

Time (UTC)

04:58

Country

CH

Event

Q1 2024 DocMorris AG Trading Statement Release
Q1 2024 DocMorris AG Trading Statement Release

Forecast

-

Previous

-
Thursday, May 2, 2024

Time (UTC)

15:00

Country

CH

Event

DocMorris AG Annual Shareholders Meeting
DocMorris AG Annual Shareholders Meeting

Forecast

-

Previous

-
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total revenue 1608.22 1726.5 1476.93 1355.54 1207.11
Revenue 1608.22 1726.5 1476.93 1355.54 1207.11
Cost of Revenue, Total 1362.59 1460.38 1227.95 1146.7 1015.64
Gross Profit 245.627 266.126 248.98 208.839 191.464
Total Operating Expense 1746 1920.28 1594.56 1401.24 1238.51
Selling/General/Admin. Expenses, Total 327.874 379.513 308.438 251.492 165.824
Depreciation / Amortization 54.882 50.437 38.616 31.149 19.13
Unusual Expense (Income) 3.907 3.962 8.282 -17.499 -0.016
Other Operating Expenses, Total -3.259 25.991 11.277 -10.598 37.926
Operating Income -137.777 -193.777 -117.633 -45.705 -31.4
Interest Income (Expense), Net Non-Operating -30.961 -31.655 -14.557 -3.789 -6.722
Other, Net -1.131 -1.252 -1.019 -0.617 -0.425
Net Income Before Taxes -169.869 -226.684 -133.209 -50.111 -38.547
Net Income After Taxes -171.115 -225.735 -135.644 -52.376 -39.1
Net Income Before Extra. Items -171.115 -225.735 -135.695 -52.358 -38.971
Net Income -171.115 -225.735 -135.695 -52.358 -38.971
Income Available to Common Excl. Extra. Items -171.115 -225.735 -135.695 -52.358 -38.971
Income Available to Common Incl. Extra. Items -171.115 -225.735 -135.695 -52.358 -38.971
Diluted Net Income -171.115 -225.735 -135.695 -52.358 -38.971
Diluted Weighted Average Shares 10.7752 9.64538 9.07641 8.66449 6.34864
Diluted EPS Excluding Extraordinary Items -15.8804 -23.4034 -14.9503 -6.04282 -6.13848
Diluted Normalized EPS -14.0974 -22.1385 -10.9801 -7.35558 -6.14012
Minority Interest 0 -0.051 0.018 0.129
Dividends per Share - Common Stock Primary Issue 0 0 0 0 0
Jun 2023 Dec 2022 Jun 2022 Dec 2021 Jun 2021
Total revenue 462.957 784.258 494.645 886.715 839.788
Revenue 462.957 784.258 494.645 886.715 839.788
Cost of Revenue, Total 363.021 659.354 414.864 761.941 704.516
Gross Profit 99.936 124.904 79.781 124.774 135.272
Total Operating Expense 511.766 855.094 561.948 1007.38 912.897
Selling/General/Admin. Expenses, Total 60.472 76.764 57.389 71.406 76.944
Depreciation / Amortization 20.674 36.254 18.713 27.746 23.397
Other Operating Expenses, Total 67.599 82.722 70.982 146.29 108.04
Operating Income -48.809 -70.836 -67.303 -120.668 -73.109
Interest Income (Expense), Net Non-Operating -9.473 -12.204 -16.898 -28.218 -4.689
Net Income Before Taxes -58.282 -83.04 -84.201 -148.886 -77.798
Net Income After Taxes -58.24 -85.028 -83.573 -148.701 -77.034
Minority Interest 0 0
Net Income Before Extra. Items -58.24 -85.028 -83.573 -148.701 -77.034
Net Income 141.605 -85.028 -86.087 -148.701 -77.034
Income Available to Common Excl. Extra. Items -58.24 -85.028 -83.573 -148.701 -77.034
Income Available to Common Incl. Extra. Items 141.605 -85.028 -86.087 -148.701 -77.034
Diluted Net Income 141.605 -85.028 -86.087 -148.701 -77.034
Diluted Weighted Average Shares 11.6836 11.166 10.3844 9.69748 9.59328
Diluted EPS Excluding Extraordinary Items -4.98477 -7.6149 -8.04791 -15.334 -8.03
Dividends per Share - Common Stock Primary Issue 0 0 0 0 0
Diluted Normalized EPS -4.57843 -6.52801 -6.79265 -14.8655 -7.50015
Total Extraordinary Items 199.845 -2.514
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total Current Assets 395.884 537.14 539.273 428.067 416.748
Cash and Short Term Investments 156.402 278.202 300.972 204.906 230.846
Cash & Equivalents 126.042 277.742 300.614 204.681 230.693
Short Term Investments 30.36 0.46 0.358 0.225 0.153
Total Receivables, Net 138.941 141.946 130.047 142.668 103.782
Accounts Receivable - Trade, Net 129.351 131.962 114.948 126.721 92.311
Total Inventory 83.18 92.464 92.941 70.608 69.4
Prepaid Expenses 17.361 24.528 15.313 9.885 12.72
Total Assets 1099.44 1269.21 1278.48 991.725 726.52
Property/Plant/Equipment, Total - Net 96.808 98.703 96.579 77.127 34.294
Property/Plant/Equipment, Total - Gross 162.741 156.567 156.401 130.844 86.091
Accumulated Depreciation, Total -65.933 -57.864 -59.822 -53.717 -51.797
Goodwill, Net 400.78 418.411 435.276 334.686 172.423
Intangibles, Net 171.126 176.951 169.261 130.567 92.202
Long Term Investments 3.569 6.332 7.478 7.193 1.333
Note Receivable - Long Term 26.486 25.025 24.184 6.018 0.94
Other Long Term Assets, Total 4.792 6.652 6.431 8.067 8.58
Total Current Liabilities 241.349 212.537 156.658 212.596 118.967
Accounts Payable 112.781 132.173 93.319 92.109 83.127
Payable/Accrued 1.73 2.708
Accrued Expenses 51.75 53.706 43.482 27.86 24.963
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 61.221 16.429 6.801 87.395 3.521
Other Current Liabilities, Total 15.597 10.229 13.056 3.502 4.648
Total Liabilities 748.666 784.291 746.741 586.073 282.944
Total Long Term Debt 493.129 552.736 563.814 350.206 144.74
Long Term Debt 460.203 518.173 527.658 313.755 142.827
Deferred Income Tax 6.865 7.647 8.277 6.216 5.47
Other Liabilities, Total 7.323 11.371 17.992 17.165 13.737
Total Equity 350.779 484.923 531.741 405.652 443.576
Common Stock 404.728 335.839 315.791 262.199 48.127
Retained Earnings (Accumulated Deficit) 75.382 234.829 284.482 183.325 416.473
Treasury Stock - Common -60.67 -31.308 -31.927 -5.219 -5.453
Other Equity, Total -68.661 -54.437 -36.605 -34.653 -15.571
Total Liabilities & Shareholders’ Equity 1099.44 1269.21 1278.48 991.725 726.52
Total Common Shares Outstanding 11.5503 10.2469 9.57174 8.6821 8.30952
Minority Interest 0 -0.11 0.03
Additional Paid-In Capital
Capital Lease Obligations 32.926 34.563 36.156 36.451 1.913
Jun 2023 Dec 2022 Jun 2022 Dec 2021 Jun 2021
Total Current Assets 405.263 395.884 432.629 537.14 496.985
Cash and Short Term Investments 282.078 156.402 199.682 278.202 252.002
Cash & Equivalents 199.712 126.042 199.185 277.742 251.672
Short Term Investments 82.366 30.36 0.497 0.46 0.33
Total Receivables, Net 52.962 145.281 142.737 144.969 140.06
Accounts Receivable - Trade, Net 44.177 129.351 127.159 131.962 124.887
Total Inventory 43.657 83.18 70.414 92.464 83.931
Prepaid Expenses 15.085 11.021 19.796 21.505 20.992
Total Assets 1010.52 1099.44 1143.79 1269.21 1251.44
Property/Plant/Equipment, Total - Net 71.096 96.808 96.383 98.703 99.098
Intangibles, Net 519.809 571.906 580.777 595.362 616.962
Long Term Investments 13.152 30.055 28.458 31.357 31.62
Other Long Term Assets, Total 1.201 4.792 5.546 6.652 6.773
Total Current Liabilities 147.134 241.349 193.029 212.537 190.744
Accounts Payable 55.667 112.781 116.933 132.173 117.687
Accrued Expenses 31.399 39.691 45.741 43.548 46.426
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 42.649 61.221 9.277 16.429 6.245
Other Current Liabilities, Total 17.419 27.656 21.078 20.387 20.386
Total Liabilities 516.457 748.666 744.729 784.291 785.298
Total Long Term Debt 361.949 493.129 544.025 552.736 566.152
Long Term Debt 334.185 460.203 511.913 518.173 529.568
Capital Lease Obligations 27.764 32.926 32.112 34.563 36.584
Deferred Income Tax 5.92 6.865 7.365 7.647 7.896
Other Liabilities, Total 1.454 7.323 0.31 11.371 20.506
Total Equity 494.064 350.779 399.064 484.923 466.14
Common Stock 409.873 404.728 340.965 335.839 316.149
Retained Earnings (Accumulated Deficit) 217.244 75.382 154.591 234.829 214.655
Treasury Stock - Common -62.393 -60.67 -30.689 -31.308 -31.607
Other Equity, Total -70.66 -68.661 -65.803 -54.437 -33.057
Total Liabilities & Shareholders’ Equity 1010.52 1099.44 1143.79 1269.21 1251.44
Total Common Shares Outstanding 11.6077 11.5503 10.2469 10.2469 9.57174
Other Current Assets, Total 11.481
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Net income/Starting Line -171.115 -225.735 -135.644 -52.376 -39.1
Cash From Operating Activities -97.287 -130.631 -67.511 -82.571 -33.227
Cash From Operating Activities 62.63 51.143 39.251 31.863 18.862
Non-Cash Items 18.014 40.145 34.961 -29.216 9.423
Cash Taxes Paid 2.184 0.031 0.518 2.069 0.783
Cash Interest Paid 15.989 14.438 12.265 4.018 1.698
Changes in Working Capital -6.816 3.816 -6.079 -32.842 -22.412
Cash From Investing Activities -89.771 -67.329 -199.856 -143.181 -140.275
Capital Expenditures -59.289 -63.477 -59.827 -41.511 -31.503
Other Investing Cash Flow Items, Total -30.482 -3.852 -140.029 -101.67 -108.772
Cash From Financing Activities 39.107 179.721 363.247 200.19 297.055
Total Cash Dividends Paid
Issuance (Retirement) of Stock, Net 42.055 187.301 206.095 0.495 184.782
Issuance (Retirement) of Debt, Net 0.506 -7.58 157.895 200.009 112.273
Foreign Exchange Effects -3.749 -4.633 0.053 -0.45 -0.624
Net Change in Cash -151.7 -22.872 95.933 -26.012 122.929
Financing Cash Flow Items -3.454 0 -0.743 -0.314
Dec 2022 Jun 2022 Dec 2021 Jun 2021
Net income/Starting Line -171.115 -86.087 -225.735 -77.034
Cash From Operating Activities -97.287 -40.236 -130.631 -16.351
Cash From Operating Activities 62.63 26.376 51.143 23.397
Non-Cash Items 18.014 6.299 40.145 10.169
Cash Taxes Paid 2.184 0.668 0.031 -0.04
Cash Interest Paid 15.989 3.208 14.438 3.154
Changes in Working Capital -6.816 13.176 3.816 27.117
Cash From Investing Activities -89.771 -29.661 -67.329 -31.311
Capital Expenditures -59.289 -30.04 -63.477 -30.015
Other Investing Cash Flow Items, Total -30.482 0.379 -3.852 -1.296
Cash From Financing Activities 39.107 -5.698 179.721 -2.527
Financing Cash Flow Items -3.454 -3.741 0 0.001
Issuance (Retirement) of Stock, Net 42.055 0.899 187.301 0.806
Issuance (Retirement) of Debt, Net 0.506 -2.856 -7.58 -3.334
Foreign Exchange Effects -3.749 -2.962 -4.633 1.247
Net Change in Cash -151.7 -78.557 -22.872 -48.942
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
UBS Asset Management (Switzerland) Investment Advisor 16.503 2261015 -7795 2023-10-17 LOW
Sands Capital Management, LLC Investment Advisor 4.432 607213 0 2022-12-31 LOW
PSquared Asset Management AG Investment Advisor/Hedge Fund 2.9792 408173 100000 2023-08-21 HIGH
BlackRock Institutional Trust Company, N.A. Investment Advisor 2.8568 391394 -28790 2023-09-11 LOW
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 1.785 244555 7013 2023-09-30 LOW
Credit Suisse Funds AG Investment Advisor/Hedge Fund 1.6043 219804 3810 2023-09-30 LOW
Zürcher Kantonalbank (Asset Management) Bank and Trust 1.3386 183391 2723 2023-09-30 LOW
Oberhaensli (Walter) Individual Investor 0.8238 112870 8608 2022-12-31
Finreon AG Investment Advisor 0.7635 104602 -6303 2023-07-31 MED
St. Galler Kantonalbank AG Investment Advisor 0.6554 89799 0 2022-10-31 MED
Capital Research Global Investors Investment Advisor 0.4624 63350 0 2023-09-30 LOW
Feuerstein (Stefan) Individual Investor 0.3859 52865 599 2022-12-31
Ziwica (Marcel) Individual Investor 0.3272 44830 2079 2022-12-31
Azimut Capital Management Sgr SpA Investment Advisor/Hedge Fund 0.3168 43400 0 2023-09-30 HIGH
BlackRock Advisors (UK) Limited Investment Advisor/Hedge Fund 0.3103 42515 -72297 2023-09-30 LOW
Globalance Bank AG Bank and Trust 0.2931 40151 0 2023-09-30 MED
zCapital AG Investment Advisor 0.2744 37600 -2400 2023-08-31 LOW
Pictet Asset Management Ltd. Investment Advisor/Hedge Fund 0.2647 36271 0 2023-06-30 LOW
Hess (Walter) Individual Investor 0.2622 35919 7746 2022-12-31
Ethenea Independent Investors S.A. Investment Advisor 0.2577 35306 0 2023-09-30 HIGH

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

ZUR ROSE GROUP N Company profile

About Zur Rose Group AG

Zur Rose Group AG is a Switzerland-based company engaged in the drug distribution sector. The Company focuses on the wholesale trade of medicines, as well as operation of a mail-order pharmacy. The Company's activities are divided into two business segments: Zur Rose and DocMorris. The Zur Rose division includes wholesale business and provides drugs to medical doctors, health insurance companies, hospitals and healthcare companies, among others. The DocMorris division manages the mail-order business for drug retail. The Company operates in Switzerland, Germany and the Netherlands through a number of subsidiaries, such as Zur Rose Suisse AG, Zur Rose Pharma GmbH, BlueCare AG, DocMorris NV, Eurapon Pharmahandel GmbH and Vitalsana BV.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Zur Rose Group AG revenues increased 17% to SF1.73B. Net loss increased 66% to SF225.7M. Revenues reflect Germany segment increase of 25% to SF1.02B, Switzerland segment increase of 5% to SF620.2M, Germany segment increase of 25% to SF1.02B, Switzerland segment increase of 5% to SF620.2M. Higher net loss reflects Marketing and acquisition expenses increase of 96% to SF118.8M (expense).

Equity composition

11/2018 rights issue, adj. fct. 1.05607, new shares offered 2665476 (late adjustment from e-mail)

Industry: Drug Retailers (NEC)

Walzmühlestrasse 49
FRAUENFELD
THURGAU 8500
CH

Income Statement

  • Annual
  • Quarterly

News

Facade on the Federal Reserve Building in Washington DC

Central Banks: which one will cut first?

Central banks dominate the calendar in March and markets try to anticipate which one will be the first one to cut

18:44, 1 March 2024

Nvidia (NVDA) confronts high expectations for Q4 results

Nvidia is arguably the hottest company on the planet. The company reports its Q4 results after the closing bell on Wednesday, the 21st of February. We preview what to expect from Nvidia’s earnings and analyse the technicals of its stock price.

12:13, 20 February 2024

UK Bank Earnings: What to expect from Lloyds, Barclays and HSBC?

UK banks will be in the spotlight in the week ahead as the European earnings season continues

16:38, 16 February 2024

Is Big Tech behind the apparent bull market rally?

While the Magnificent Seven have dominated market momentum in recent months, it’s not true that they are the sole drivers of the recent rally in equity markets.

16:05, 8 February 2024

US Earnings Week Ahead: Walt Disney, Uber, and Pepsi Co.

The last of the Magnificent Seven have reported, delivering mixed results. Meanwhile, according to FactSet, the S&P 500 is set for negative earnings growth for Q4, with estimates for the next quarter also downgraded.

16:24, 2 February 2024

Bank of England preview: will updated projections show more cuts are expected in 2024?

Markets have no doubt that the BoE will keep its rate unchanged

15:43, 31 January 2024

Meta Platforms Q4 earnings forecast to surge on solid ad revenues

Meta Platforms (META) reports its Q4 results after Wall Street’s closing bell on February 1, 2024. We preview what to expect from the results and analyse the stock’s technicals.

15:33, 31 January 2024

People also watch

BTC/USD

62,039.55 Price
-1.050% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 106.00

Gold

2,083.15 Price
+1.890% 1D Chg, %
Long position overnight fee -0.0191%
Short position overnight fee 0.0108%
Overnight fee time 22:00 (UTC)
Spread 0.50

Oil - Crude

79.49 Price
+1.850% 1D Chg, %
Long position overnight fee 0.0266%
Short position overnight fee -0.0485%
Overnight fee time 22:00 (UTC)
Spread 0.030

XRP/USD

0.64 Price
+5.310% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 22:00 (UTC)
Spread 0.01168

Still looking for a broker you can trust?

Join the 580.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading